Loading company…
Q Therapeutics develops human-cell-based therapies for central nervous system diseases.
Q Therapeutics develops Q-Cells, human glial progenitor cells intended to support and repair neuronal function in the brain and spinal cord. Founded by M. Mahendra, the company is based in Salt Lake City, US. It raised USD 15.00 mn in a Series B round led by Signal Peak Ventures on February 15, 2008.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in